Policy Guidelines for NIDDK Ongoing Clinical Research Studies Eligible for Ancillary Studies : NIDDK

Policy Guidelines for NIDDK Ongoing Clinical Research Studies Eligible for Ancillary Studies

Please note that the ancillary study policies for some studies are currently under development. As policies become available, they will be posted on this website under the appropriate study.

African American Study of Kidney Disease and Hypertension (AASK)

Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL)

The Boston Area Community Health (BACH) Survey

Biliary Atresia Research Consortium (BARC)

The Complementary and Alternative Medicine for Urological Symptoms (CAMUS)

The Chronic Renal Insufficiency Cohort (CRIC) Study (pdf-38KB)

TrialPediatric Chronic Renal Insufficiency Cohort StudyConsortium for Radiologic Imagining of Polycystic Kidney Disease (CRISP)

The Dialysis Access Consortium (DAC) (pdf-20KB)

Cohort StudyDiabetes Prevention Program Outcomes Study (DPPOS) (pdf-28KB)

Type 1 Diabetes TrialNetThe Epidemiology of Diabetes Interventions and Complications Study (EDIC) (pdf-14KB)

Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial (pdf-24KB)

Familial Investigator of Nephropathy of Diabetes (FIND) (pdf-16KB)

Focal Segmental Glomerular Sclerosis (FSGS) Trial in Young Adults and Children (pdf-30KB)

Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

Look AHEAD: Action for Health in Diabetes

The Minimally Invasive Surgical Therapy (MIST)

Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)

Studies to Treat or Prevent Pediatric Type 2 Diabetes (STOPP-T2D)

The Environmental Determinants of Diabetes in the Young (TEDDY) Consortium (pdf-20KB)

The Urinary Incontinence Treatment Network (UITN) (pdf-77KB)

Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep C)

Coming Soon

Peginterferon and Ribavirin for Pediatric Patients with Chronic Hepatitis C (Peds-C)

The Drug-Induced Liver Injury Network (DILIN)

High-dose Ursodiol Therapy of Primary Sclerosing Cholangitis (HUSC)

LABS (Longitudinal Assessment of Bariatric Surgery) ConsortiumThe 

Frequent Dialysis Clinical Trials HALT-PKD

Page last updated: November 25, 2008

General inquiries may be addressed to: Office of Communications & Public Liaison
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services   USA.gov is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation